Rotator Cuff Tears
Conditions
Brief summary
This is a prospective, parallel group, open-label, multi- center, randomized study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.
Detailed description
Study Objectives: Primary: • To evaluate clinical outcomes of both a formalized or an at-home rehabilitation program when used in conjunction with the InSpace device as compared to the corresponding InSpace Pivotal study results. * To demonstrate consistency of each intervention group with the corresponding historical control study results. * To demonstrate that comparable clinical outcomes can be achieved for each intervention group. Secondary: • Change in clinical outcomes compared to baseline.
Interventions
DEVICEInSpace Subacromial Tissue Spacer
Rotator Cuff Tear Treatment
Sponsors
Stryker Endoscopy
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Subjects MUST meet ALL the following criteria to be included in the study: * The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment * Is male or female ≥ sixty-five (65) years of age * Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT: * Measuring ≥ 5 cm in diameter * Involving ≥ two tendons * Functional deltoid muscle and preserved passive range of motion on physical examination * Documented VAS score \> 30 mm pain * Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following: * Oral analgesics * Anti-inflammatory medication (e.g., ibuprofen, naproxen) * Corticosteroid injection(s) * Physical therapy * Activity modification * Rest (sling used) * Must be able to read and understand the approved Informed Consent Form (written and oral) * Must be in general good health (as determined by the Investigator) based on screening assessments and medical history * Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection Intra-operative Inclusion Criteria Subjects MUST meet the following criteria to be randomized in the study: * Full thickness tear * Tear size ≥ 5 cm in diameter * Tear involving ≥ two tendons
Exclusion criteria
Subjects will be excluded from the study, if they meet ANY of the following individual
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in American Shoulder and Elbow (ASES) Score | Day 0 through Month 12 | This is a subject self-report questionnaire and Investigator assessment questionnaire. The subject portion collects information on activities of daily living (i.e., 10 questions). The Investigator assessment portion documents ROM (forward elevation/flexion, external rotation, internal rotation, cross-body adduction), signs, strength, and instability. ASES minimal clinical important difference (MCID) and substantial clinical benefit (SCB) have been previously described for the ASES score in patients undergoing rotator cuff repair as 11.1 and 17.5, respectively. Change in American Shoulder and Elbow Surgeons (ASES) Score will be expressed as the percentages demonstrating a minimal clinical important difference (MCID; ASES ≥ 11.1) and the substantial clinical benefit (SCB; ASES ≥ 17.5) in ASES from baseline at Month 12. Minimum value: 0, Maximum value: 100 (with a higher score indicating a better outcome). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Western Ontario Rotator Cuff (WORC) Score | Day 0 through Month 24 | Change in WORC Score from baseline. Minimum value: 2,100, Maximum value: 0 (with a lower score indicating a better outcome). This is a subject self-report questionnaire that is a disease-specific Quality of Life Measurement Tool specifically designed to evaluate quality of life in persons with pathology of the rotator cuff. It is comprised of 21 items in 5 domains (i.e., physical symptoms, sports and recreation, work, lifestyle, emotions). |
| Change in Constant Score (CS) Outcome Score | Day 0 through Month 24 | Change in CS Outcome Score from baseline. Minimum value: 0, Maximum value: 100 (with a higher score indicating a better outcome). This is a self-reported questions as well as Investigator or designee performed assessment of the shoulder. The tool is divided into four subscales: pain, activities of daily living, strength and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder. |
| Change in EuroQol 5-Dimensions Questionnaire (EQ-5D-5L) Score | Day 0 through Month 24 | Change in EQ-5D-5L Score from baseline. Minimum value: 0, Maximum value: 100 (with a higher score indicating a better outcome). This is a subject self-report questionnaire to measure health-related quality of life (HRQOL). It consists of 5 questions capturing the subject's current health across five dimensions (i.e., mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). It also includes a numerical visual analogue scale (EQ-VAS). |
| Change in Visual Analog Scale (VAS) Score | Day 0 through Month 24 | Change in VAS Score from baseline. This is a subject self-report questionnaire to measure pain. The patient marks on the line the point that they feel represents their perception of their current state. The amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. (An extreme amount of pain would be considered a worse outcome) |
| Change in Range of Motion (ROM) Score | Day 0 through Month 24 | Change in ROM Score from baseline. Minimum value: 0, Maximum value: 180 (with a higher score indicating a better outcome). |
| Safety Assessment | Day 0 through Month 24 | • Safety will be evaluated by type, frequency, severity, and relatedness of adverse events to study intervention at each follow-up visit through Month 24 |
| Patient's satisfaction with their procedure | Month 12 and Month 24 | Patient Satisfaction Score at Month 12 and Month 24. This is a single-question to evaluate the patients' current state of satisfaction. Responses are binary with Yes or No answers. ('Yes' would be considered a positive outcome) |
| Costing | Day 0 through Month 24 | Costs associated with all visits |
| Time to Recovery | Day 0 through Month 24 | Time to recovery by cumulative time between discharge and return to driving |
| Analgesia Use | Day 0 through Month 24 | Analgesia use (drug and frequency) |
| Change in Single Assessment Numeric Evaluation (SANE) Score | Day 0 through Month 24 | Change in SANE from baseline. Minimum value: 0%, Maximum value: 100% (with 100% being normal). This is a subject self-report questionnaire to measure function. The patient marks on the line the point that they feel represents their perception of their current state of functional improvement. Example: How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)? |
Countries
United States
Contacts
Primary ContactHayley Taylor, MS
Outcome results
None listed